TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.83
(-13.29%)
TWD 7.83
(-13.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.73 Million TWD | 66.88% |
| 2022 | -15.99 Million TWD | 42.66% |
| 2021 | -9.14 Million TWD | 77.7% |
| 2020 | -41.02 Million TWD | -394.23% |
| 2019 | 13.94 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.42 Million TWD | -2.78% |
| 2024 Q1 | -6.25 Million TWD | 31.26% |
| 2023 Q1 | 6.45 Million TWD | 243.46% |
| 2023 Q3 | -9.09 Million TWD | -241.03% |
| 2023 Q4 | -9.09 Million TWD | 0.0% |
| 2023 FY | - TWD | 66.88% |
| 2023 Q2 | 6.45 Million TWD | 0.0% |
| 2022 Q3 | -4.49 Million TWD | 0.0% |
| 2022 FY | - TWD | 42.66% |
| 2022 Q4 | -4.49 Million TWD | 0.0% |
| 2021 FY | - TWD | 77.7% |
| 2020 FY | - TWD | -394.23% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 96.244% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 100.441% |
| Level Biotechnology Inc. | 98.7 Million TWD | 101.76% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 96.117% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 97.591% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 93.116% |
| GlycoNex Incorporation | -126.82 Million TWD | 98.63% |
| VBI | -6.97 Million TWD | 75.086% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 98.791% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 107.964% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 90.201% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 98.324% |
| Visgeneer Inc. | 973 Thousand TWD | 278.52% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 99.488% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 100.185% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 101.74% |
| Neith Corporation | -33.61 Million TWD | 94.832% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 99.825% |
| Enimmune corporation | -228.96 Million TWD | 99.241% |
| TaiRx, Inc. | -208.64 Million TWD | 99.167% |
| CHO Pharma, Inc. | -277.73 Million TWD | 99.375% |
| EirGenix Inc. | -664.4 Million TWD | 99.739% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 102.35% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 102.512% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 99.838% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 98.464% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 104.986% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 97.214% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 93.395% |
| RBC Bioscience Corporation | 36.54 Million TWD | 104.753% |
| BiOptic Inc. | 65.03 Million TWD | 102.671% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 99.745% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 94.737% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 96.837% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 100.401% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 97.831% |
| NaviFUS Corp. | -55.79 Million TWD | 96.887% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 89.535% |
| Sinew Pharma Inc. | -163.63 Million TWD | 98.938% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 97.176% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 100.903% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 99.234% |
| AP Biosciences Inc | -325.51 Million TWD | 99.466% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 99.834% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 95.154% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 105.963% |
| Intech Biopharm Corporation | -219.58 Million TWD | 99.209% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 99.742% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 96.136% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 98.92% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 100.265% |
| TCI GENE Inc. | 25.98 Million TWD | 106.686% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 98.43% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 99.388% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 98.81% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 112.542% |
| PharmaEngine, Inc. | 347.3 Million TWD | 100.5% |
| Savior Lifetec Corporation | 219.6 Million TWD | 100.791% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 101.009% |
| OBI Pharma, Inc. | -855.08 Million TWD | 99.797% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 98.123% |
| Acepodia, Inc. | -764.51 Million TWD | 99.773% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 99.622% |